Elimination of SOX2/OCT4-Associated Prostate Cancer Stem Cells Blocks Tumor Development and Enhances Therapeutic Response
SOX2 and OCT4 are key regulators of embryonic stem cell pluripotency. They are overexpressed in prostate cancers and have been associated with cancer stem cell (CSC) properties. However, reliable tools for detecting and targeting SOX2/OCT4-overexpressing cells are lacking, limiting our understanding...
Main Authors: | Prasanna Kumar Vaddi, Mark A. Stamnes, Huojun Cao, Songhai Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1331 |
Similar Items
-
Association between SOX2 and OCT4 expression and the chemoradiation therapeutic response in undifferentiated non-keratinizing nasopharyngeal carcinoma
by: Lisnawati Rachmadi, et al.
Published: (2020-12-01) -
Effect of overexpression of Oct4 and Sox2 genes on the biological and oncological characteristics of gastric cancer cells
by: Chen B, et al.
Published: (2019-06-01) -
Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
by: Mikella Robinson, et al.
Published: (2021-01-01) -
Expression of SOX2 and OCT4 in odontogenic cysts and tumors
by: Ekarat Phattarataratip, et al.
Published: (2021-07-01) -
Study of SOX2, OCT4 and NANOG Genes Expression in Peripheral Blood of Patients with Non-small Cell Lung Cancer (NSCLC)
by: Niloofar Mojtahedifard, et al.
Published: (2018-01-01)